Service of Private Sector Persons on Food and Drug Administration Advisory Committees

Department of Justice Office of Legal Counsel·Decided June 29, 1978·Published

Opinion

June 2 9 , 1978

78-37 MEMORANDUM OPINION FOR THE CHIEF COUNSEL, FOOD AND DRUG ADMINISTRATION

Advisory Committees— Food and Drug Administration— Conflicts of Interest (18 U.S.C. § 208)

This responds to your inquiry regarding the scope of the term “ particular matter” as used in 18 U.S.C. § 208(a), in connection with the service of persons from the private sector on advisory committees in the Food and Drug Administration (FDA).

Section 208 requires an officer or employee of the executive branch to disqualify himself in any “ particular matter(s)” in which, to his knowledge, he, his spouse or minor child, or an organization in which he is serving as an officer, director, trustee, partner, or employee has a financial interest. Thus, the meaning of the term determines the sort of occasions on which an advisory committee member must disqualify himself under the statute.

We understand that the advisory committees involved in the inquiry are utilized by FDA in the areas of premarketing approval of prescription drugs, classification of medical devices, and drafting of monographs for ingredients used in over-the-counter drugs. Your Office indicated in conversations with this Office last spring that without the use of these advisory committees, the members of which are expert in the areas involved, FDA could not discharge its statutory responsibilities at the level which the safety and the health of the public warrant.

Four examples of participation by members of various FDA advisory committees were given to us. Three of the members were on the faculties of universities that received research grants from pharmaceutical firms or manufacturers of medical devices. At least two actually worked on the university projects funded by the firms. You state that none of the individuals participated as an advisory committee member in any deliberations relating specifically to the firm or the product of the firm that funded the particular research grant to his university, but that each did participate in the committee’s deliberations relating to general categories of medical devices or ingredients of

a certain classification of products, some of which were manufactured by the firm that funded the research.

The fourth example involved a member of the National Advisory Food and Drug Committee who had substantial holdings in a cattle feedlot operation and who participated in deliberations concerning the desirability of continuing the use of low levels of antibiotics in animal feeds for prophylactic purposes and growth promotion. He was not a manufacturer of any of the products involved and no competitive advantage or disadvantage would be conferred upon him vis-a-vis other members of his industry1 regardless of the Agency’s ultimate decision. It was also pointed out that this example and those of the university faculty members involved advisory committees established to advise the FDA about matters that involve segments of the regulated industry as a whole rather than particular products or companies.

The relevant statute, 18 U.S.C. §208(a), provides:

(a) Except as permitted by subsection (b) hereof, whoever, being an officer or employee of the executive branch of the United States Government, of any independent agency of the United States, or of the District of Columbia, including a special Government employee, participates personally and substantially as a Government officer or employee, through decision approval, disapproval, recommendation, the rendering of advice, investigation, or otherwise, in a judicial or other proceeding, application, request for a ruling or other determina­ tion, contract, claim,- controversy, charge, accusation, arrest, or other particular matter in which, to his knowledge, he, his spouse, minor child, partner, organization in which he is serving as officer, director, trustee, partner or employee, or any person or organization with whom he is negotiating or has any arrangement concerning prospective employment, has a financial interest—

Shall be fined not more than $10,000, or imprisoned not more than two years, or both.

You have informed us that the members of FDA advisory committees are designated as special Government employees. The question presented is whether participation in deliberations of the committees concerning a class of related products or an ingredient common to many products involves participa­

n t was not indicated w hether the phrase " h is in d u stry " refers to the feedlot industry or to the cattle industry as a w hole. It is possible, for exam ple, that the banning o f antibiotics in anim al feeds would work to the com petitive advantage o f those portions o f the cattle industry that do not rely on animal feeds to the degree that feedlot operators do.

tion in a “ particular matter” within the meaning of § 208(a). We believe that it does.2 As an initial matter, some confusion regarding the scope of § 208(a) may arise because of the use of the word “ particular.” It is our understanding that the word “ particular” was included to make clear that an individual would not be disqualified from an entire area or range of activities merely because he might have a financial interest in a certain decision, proceeding, transaction, or recommendation arising within that area or range; disqualification is only required in the “ particular” matter, not as to the entire area or range. C f, Hearings on Federal Conflict o f Interest Legislation before Subcommittee No. 5 o f the House Judiciary Committee, 87th Cong., 1st sess. 38 (1961). But it was evidently the purpose to make the enumeration of particular matters in § 208(a) and the other sections of the conflict of interest laws, in which the same enumeration appears, “ comprehensive of all matters that come before a Federal department or agency.” Id.; see also id., at 41. Thus, it has been and continues to be our view that § 208(a) applies to any discrete or identifiable decision, recommendation, or other matter even though its outcome may have a rather broad impact. Accordingly, the word “ particular” serves to limit the application of § 208(a) in terms of discrete areas of the employee’s activities, not the number of outside parties who may be affected.

Our reading of § 208(a) in this manner finds support as well in the structure of the statute and its contemporaneous interpretation. To determine the proper scope of the language of §208(a), it must be examined as part of a comprehensive statutory scheme rather than in isolation. Utilizing that approach, we find, for example, that 18 U.S.C. § 203(a) and the first paragraph of §205 both bar regular Government employees from representing other parties in all “ particular matters” involving the United States. However § 203(c) and the second paragraph of § 205 impose narrower restrictions on special Government employees, barring them from acting as agent or attorney only in “ particular matter[s] involving a specific party or parties” that are pending before the Departments or agencies in which they are serving. Similarly, the postemployment statute, 18 U.S.C. § 207, bars a former Government employee, whether regular

2There may be som e question w hether a "financial interest” within the m eaning o f the statute is present on the facts involving the three faculty m em bers. It may be that if the research grant to a university concerns the types o f products involved in the advisory com m ittee’s deliberations, the com m ittee’s deliberations could influence F D A 's decision with respect to the products. T his could in turn have an im pact on the continuity o f a research grant pertaining to the same products. But it is arguable that neither the faculty m em ber nor his em ploying university has a "financial interest” in the advisory com m ittee’s recom m endations where the university's research has no relation to the products the advisory com m ittee is considering.

Free access — add to your briefcase to read the full text and ask questions with AI

Service of Private Sector Persons on Food and Drug Administration Advisory Committees, (olc 1978).

Service of Private Sector Persons on Food and Drug Administration Advisory Committees (Service of Private Sector Persons on Food and Drug Administration Advisory Committees) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related